Etilamfetamine

Ethylamphetamine
INN: Etilamfetamine

Clinical data
Routes of administration	Oral, sublingual, insufflated, inhaled (vaporized), intravenous, rectal
ATC code	A08AA06 (WHO)
Legal status
Legal status	BR: Class B1 (Psychoactive drugs)[1] CA: Schedule I DE: Anlage II (Authorized trade only, not prescriptible) UK: Class C US: Schedule I
Pharmacokinetic data
Metabolism	Hepatic
Excretion	Renal
Identifiers
IUPAC name N-Ethyl-1-phenyl-propan-2-amine
CAS Number	457-87-4 Y
PubChem CID	9982
ChemSpider	9588 Y
UNII	022YON1XMX
KEGG	D07114 Y
ChEMBL	ChEMBL276443 Y
CompTox Dashboard (EPA)	DTXSID10860359
ECHA InfoCard	100.230.711
Chemical and physical data
Formula	C11H17N
Molar mass	163.264 g·mol−1
3D model (JSmol)	Interactive image
SMILES N(C(Cc1ccccc1)C)CC
InChI InChI=1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3 Y Key:YAGBSNMZQKEFCO-UHFFFAOYSA-N Y
(verify)

Etilamfetamine, also known as N-ethylamphetamine and formerly sold under the brand names Apetinil and Adiparthrol, is a stimulant drug of the amphetamine family. It was invented in the early 20th century and was subsequently used as an anorectic or appetite suppressant in the 1950s,^[2] but was not as commonly used as other amphetamines such as amphetamine, methamphetamine, and benzphetamine, and was largely discontinued once newer drugs such as phenmetrazine were introduced.